GETINGE MEDICAL TECHNOLOGY RDI II

RDI investments related to medical technology in the areas of surgery, intensive care, infection control, care ergonomics and wound care during the period of 2014-2017.

The project concerns the company's research and development (R&D) of various new products and product improvements in Medical Systems with a particular focus on i) cardiac surgery, ii) cardiopulmonary and cardiac assist, iii) surgical workplaces and iv) critical care. The project is covering the entire product development from pre-clinical studies up to clinical trials. The R&D activities will take place at the company’s innovation centres in Sweden, Germany and France.

The project mainly concerns investments in R&D that are expected to be carried out in existing facilities without changing their already authorized scope and would therefore not require an EIA under the Directive 2011/92/EU. Full environmental details will be verified during the appraisal.

The promoter is a private company not operating in the Utilities sector and not having the status of a contracting authority. Thus it is not covered by EU Directives on procurement. However, the promoter’s procurement procedures are expected to be in line with EIB guidelines for private sector projects. The Bank’s services will verify details during the project due diligence.

The Risk Sharing Finance Facility (RSFF) is an innovative credit risk sharing scheme jointly set up by the European Commission and the European Investment Bank to improve access to debt financing for private companies or public institutions promoting activities with a higher financial risk profile in the fields of research, technological development, demonstration and innovation investments.